AbstractObjectivesThere exists a lack of extrapolation methods for long-term survival analysis when censored rates are high (25–50%). This study aimed at estimating life expectancy (LE) after the diagnosis of cancer and the expected years of life lost (EYLL) using a newly developed semiparametric method.MethodsPatients (n = 425,294) diagnosed with 17 different types of major cancer were enrolled. All of the patients were registered with the Taiwan Cancer Registry between 1990 and 2001; their survivals were followed through the end of 2004. The survival function for an age- and sex-matched reference population was generated using the Monte Carlo method from the life table of the general population. Lifetime survival of the cancer patients (u...
AbstractBy employing a novel semi-parametric extrapolation method, the life expectancies after the f...
Net survival, the one that would be observed if cancer were the only cause of death, is the most app...
Objectives: Survival extrapolation of trial outcomes is required for health economic evaluation. Gen...
Objectives: There exists a lack of extrapolation methods for long-term survival analysis when censor...
[[sponsorship]]統計科學研究所[[note]]已出版;[SCI],[SSCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gat...
AbstractPurposeThe study aims to quantify the expected impacts of different cancers through multiply...
BACKGROUND: The life expectancy of cancer patients, and the loss in expectation of life as compared ...
Abstract Background The critical implications of the expected years of life lost (EYLL) index of can...
The overarching aim of this work has been to develop and apply statistical methods for estimating ca...
Cancer patient survival is the single most important measure of cancer patient care. By quantifying ...
The aims of this study were to provide life expectancy (LE) estimates of cancer patients at diagnosi...
[[abstract]]Objectives: Estimates of expected lifetime survivals and lifetime costs for cohort with ...
BACKGROUND: Survival extrapolation is essential in cost-effectiveness analysis to quantify the lifet...
Background: It is often important to extrapolate survival estimates beyond the limited follow-up ti...
Abstract Background Within cancer care, dynamic evaluations of the loss in expectation of life provi...
AbstractBy employing a novel semi-parametric extrapolation method, the life expectancies after the f...
Net survival, the one that would be observed if cancer were the only cause of death, is the most app...
Objectives: Survival extrapolation of trial outcomes is required for health economic evaluation. Gen...
Objectives: There exists a lack of extrapolation methods for long-term survival analysis when censor...
[[sponsorship]]統計科學研究所[[note]]已出版;[SCI],[SSCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gat...
AbstractPurposeThe study aims to quantify the expected impacts of different cancers through multiply...
BACKGROUND: The life expectancy of cancer patients, and the loss in expectation of life as compared ...
Abstract Background The critical implications of the expected years of life lost (EYLL) index of can...
The overarching aim of this work has been to develop and apply statistical methods for estimating ca...
Cancer patient survival is the single most important measure of cancer patient care. By quantifying ...
The aims of this study were to provide life expectancy (LE) estimates of cancer patients at diagnosi...
[[abstract]]Objectives: Estimates of expected lifetime survivals and lifetime costs for cohort with ...
BACKGROUND: Survival extrapolation is essential in cost-effectiveness analysis to quantify the lifet...
Background: It is often important to extrapolate survival estimates beyond the limited follow-up ti...
Abstract Background Within cancer care, dynamic evaluations of the loss in expectation of life provi...
AbstractBy employing a novel semi-parametric extrapolation method, the life expectancies after the f...
Net survival, the one that would be observed if cancer were the only cause of death, is the most app...
Objectives: Survival extrapolation of trial outcomes is required for health economic evaluation. Gen...